Intellia Therapeutics Cash from Operations (TTM)

Intellia Therapeutics Inc (NTLA)

40.96 +2.80 (+7.34%) USD | NASDAQ | Jun 02, 16:00

40.95 -0.01 (-0.02%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
March 31, 2023	-362.81M
December 31, 2022	-333.29M
September 30, 2022	-298.07M
June 30, 2022	-284.56M
March 31, 2022	-252.46M
December 31, 2021	-225.03M
September 30, 2021	-210.60M
June 30, 2021	-174.14M
March 31, 2021	-63.74M
December 31, 2020	-49.91M
September 30, 2020	-38.35M
June 30, 2020	-35.24M
March 31, 2020	-120.33M
December 31, 2019	-103.24M
September 30, 2019	-83.12M

Date	Value
June 30, 2019	-70.12M
March 31, 2019	-64.94M
December 31, 2018	-61.26M
September 30, 2018	-74.02M
June 30, 2018	-78.46M
March 31, 2018	-71.65M
December 31, 2017	-65.28M
September 30, 2017	-58.38M
June 30, 2017	-49.10M
March 31, 2017	34.13M
December 31, 2016	36.11M
September 30, 2016	45.03M
June 30, 2016	49.37M
March 31, 2016	-16.01M
December 31, 2015	-1.763M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-362.81M

Minimum

Mar 2023

-35.24M

Maximum

Jun 2020

-149.19M

Average

-93.18M

Median

Cash from Operations (TTM) Benchmarks